Abstract
Incontinentia pigmenti (Bloch-Sulzberger syndrome) is a multisystem disorder with classical changing skin lesions. The other systems that are involved include the central nervous system, eye, hair, teeth, musculoskeletal system and, occasionally, the cardiovascular system. We report a neonate with a diagnosis of incontinentia pigmenti who presented at birth with pulmonary hypertension. This presentation has not been described in the literature.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Garrod AE . Peculiar pigmentation of the skin of the infant. Trans Clin Soc London 1906;39:216.
Shah SN, Gibbs S, Upton CJ, Pickworth FE, Garioch JJ . Incontinentia pigmenti associated with cerebral palsy and cerebral leukomalacia: a case report and literature review. Pediatr Dermatol 2003;20:491–494.
Bloch B . Eightumliche bisher nicht besmhriebene pigmentaffektion (incontenentia pigmenti). Schweiz Med Wehnschi 1926;7:404–405.
Kasman-Kellner B, Jurin-Bunte B, Ruprecht KW . Incontinentia pigmenti (Bloch–Sulzberger-syndrome): case report and differential diagnosis to related dermato-ocular syndromes. Ophthalmologica 1999;213:63–69.
Wood AE, Boyle D, O'Hara MD, Cleand J . Mitral annuloplasty in endomyocardial fibrosis: alternative to valve replacement. Ann Thorac Surg 1982;34:446–451.
Vachvanichsanong P, Jinorose U, Sangnuachua P . Trisomy 14 mosaicism in a 5-year-old boy. Am J Med Genet 1991;40:80–83.
Miteva L, Nikolova A . Incontinentia pigmenti: a case associated with cardiovascular anomalies. Pediatr Dermatol 2001;18:54–56.
Triki C, Devictor D, Kah S, et al. Cerebral complications of incontinentia pigmenti. A clinicopathological study of a case. Rev Neurol (Paris) 1992;148:773–776.
Smahi A, Courtois G, Vabres P, et al. Genomic rearrangement in NEMO impairs NF-kappaB activation and is a cause of incontinentia pigmenti. The international Incontinentia Pigmenti (IP) Consortium. Nature 2000;405:466–472.
Goldberg MF, Custis PH . Retinal and other manifestations of Incontinentia pigmenti (Bloch–Sulzberger syndrome). Ophthalmology 1993;100:1645–1654.
Wiklund DA, Weston WL . Incontinentia pigmenti: a four-generation study. Arch Dermatol 1980;116:701–703.
Carney RG . Incontinentia pigmenti. A world statistical analysis. Arch Dermatol 1976;112:535–542.
Harre J, Millikan LE . Linear and whorled pigmentation. Int J Dermatol 1994;33:529–537.
Moss C, Ince P . Anhidrotic and achromians lesions in incontinentia pigmenti. Br J Dermatol 1987;116:839–849.
Worret WI, Nordquist RE, Burgdorf WH . Abnormal cutaneous nerves in incontinentia pigmenti. Ultrastruct Pathol 1988;12:449–454.
Rott HD . Partial sweat gland aplasia in incontinentia pigmenti Bloch–Sulzberger. Implications for nosologic classification. Clin Genet 1984;26:36–38.
Sefiani A, Abel L, Heuertz S, et al. The gene for incontinentia pigmenti is assigned to Xq28. Genomics 1989;4:427–429.
Smahi A, Hyden-Granskog C, Peterlin B, et al. The gene for the familial form of incontinentia pigmenti (IP2) maps to the distal part of Xq28. Hum Mol Genet 1994;3:273–278.
Jin DY, Jeang KT . Isolation of full-length cDNA and chromosomal localization of human NF-kappaB modulator NEMO to Xq28. J Biomed Sci 1999;6:115–120.
Baldwin Jr AS . The NF-kappa B and I kappa B proteins: new discoveries and insights. Annu Rev Immunol 1996;14:649–683.
Verma IM, Stevenson JK, Schwarz EM, Van Antwerp D, Miyamoto S . Rel/NF-kappa B/I kappa B family: intimate tales of association and dissociation. Genes Dev 1995;9:2723–2735.
Makris C, Godfrey VL, Krahn-Senftleben G, et al. Female mice heterozygous for IKK gamma/NEMO deficiencies develop a dermatopathy similar to the human X-linked disorder incontinentia pigmenti. Mol Cell 2000;5:969–979.
Raychaudhuri B, Dweik R, Connors MJ, et al. Nitric oxide blocks nuclear factor-kappaB activation in alveolar macrophages. Am J Respir Cell Mol Biol 1999;21:311–316.
Ortiz LA, Champion HC, Lasky JA, et al. Enalapril protects mice from pulmonary hypertension by inhibiting TNF-mediated activation of NF-kappaB and AP-1. Am J Physiol Lung Cell Mol Physiol 2002;282:L1209–L1221.
Hennel SJ, Ekert PG, Volpe JJ, Inder TE . Insights into the pathogenesis of cerebral lesions in incontinentia pigmenti. Pediatr Neurol 2003;29:148–150.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Godambe, S., McNamara, P., Rajguru, M. et al. Unusual Neonatal Presentation of Incontinentia Pigmenti with Persistent Pulmonary Hypertension of the Newborn: A Case Report. J Perinatol 25, 289–292 (2005). https://doi.org/10.1038/sj.jp.7211250
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.jp.7211250
This article is cited by
-
Therapy resistant neonatal seizures, linear vesicular rash, and unusually early neuroradiological changes: incontinentia pigmenti
European Journal of Pediatrics (2008)